| Literature DB >> 28560683 |
Yaseen M Arabi1, Hasan M Al-Dorzi2, Ahmed Alamry2, Ra'ed Hijazi2, Sami Alsolamy2, Majid Al Salamah2, Hani M Tamim2,3, Saad Al-Qahtani2, Abdulaziz Al-Dawood2, Abdellatif M Marini2, Fatimah H Al Ehnidi2, Shihab Mundekkadan2, Amal Matroud2, Mohamed S Mohamed2, Saadi Taher2.
Abstract
BACKGROUND: Compliance with the clinical practice guidelines of sepsis management has been low. The objective of our study was to describe the results of implementing a multifaceted intervention including an electronic alert (e-alert) with a sepsis response team (SRT) on the outcome of patients with sepsis and septic shock presenting to the emergency department.Entities:
Keywords: Emergency department; Health service administration; Hospital mortality; Intensive care unit; Patient safety; Quality improvement; Sepsis; Sepsis resuscitation bundle; Shock
Year: 2017 PMID: 28560683 PMCID: PMC5449351 DOI: 10.1186/s13613-017-0280-7
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Baseline characteristics of patients with sepsis and septic shock on presentation in the three study phases: pre-intervention (A), intervention phase I (B) and intervention phase II (C)
| All patients | Pre-intervention | Intervention phase I | Intervention phase II | Crude |
| ||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| B vs. A | C vs. B | C vs. A | B vs. A | C vs. B | C vs. A | |
| Source of sepsis, no. (%) | |||||||||
| Pneumonia | 228 (52.3) | 93 (47.7) | 281 (40.2) | 0.29 | 0.06 | <0.0001 | 0.99 | 0.98 | 0.96 |
| Urinary tract infection | 70 (16.1) | 28 (14.4) | 107 (15.3) | 0.59 | 0.74 | 0.74 | 0.78 | 0.90 | 0.38 |
| Acute abdominal infection | 40 (9.2) | 8 (3.6) | 47 (6.7) | 0.03 | 0.18 | 0.13 | 0.05 | 0.37 | 0.17 |
| Soft tissue infection | 8 (1.8) | 8 (4.1) | 32 (4.6) | 0.10 | 0.78 | 0.01 | 0.42 | 0.84 | 0.56 |
| Other infections | 138 (31.7) | 68 (34.9) | 254 (36.3) | 0.43 | 0.71 | 0.11 | 0.92 | 0.60 | 0.48 |
| Signs and symptoms, no. (%) | |||||||||
| Hyperthermiaa | 114 (26.2) | 52 (26.7) | 172 (24.6) | 0.89 | 0.56 | 0.56 | 0.81 | 0.15 | 0.47 |
| Hypothermiaa | 34 (7.8) | 6 (3.1) | 7 (1.0) | 0.02 | 0.04 | <0.0001 | 0.99 | 0.86 | 0.81 |
| Acutely altered mental status | 157 (36.0) | 48 (24.6) | 59 (8.4) | 0.005 | <0.0001 | <0.0001 | 0.98 | 0.67 | 0.71 |
| Chills and rigors | 11 (2.5) | 7 (3.6) | 2 (0.3) | 0.46 | 0.001 | 0.0006 | 0.55 | 0.0007 | 0.02 |
| Tachycardiaa | 354 (81.2) | 168 (86.2) | 624 (89.3) | 0.13 | 0.23 | 0.0001 | 0.76 | 0.44 | 0.49 |
| Tachypneaa | 368 (84.4) | 174 (89.2) | 583 (83.4) | 0.11 | 0.05 | 0.66 | 0.44 | 0.34 | 0.92 |
| Hypotensiona | 368 (84.4) | 111 (56.9) | 265 (37.9) | <0.0001 | <0.0001 | <0.0001 | 0.004 | 0.42 | <0.0001 |
| Hypoxiaa | 101 (23.2) | 79 (40.5) | 227 (32.5) | <0.0001 | 0.04 | 0.0008 | 0.94 | 0.96 | 0.99 |
| Laboratory findings, no. (%) | |||||||||
| Leukocytosisa | 237 (54.4) | 85 (43.6) | 229 (32.8) | 0.01 | 0.005 | <0.0001 | 0.14 | 0.003 | <0.0001 |
| Leukopeniaa | 36 (8.3) | 6 (3.1) | 21 (3.0) | 0.02 | 0.96 | <0.0001 | 0.99 | 0.99 | 0.92 |
| Increased creatininea | 107 (24.5) | 4 (2.1) | 1 (0.1) | <0.0001 | 0.009 | <0.0001 | 0.97 | 0.99 | 0.68 |
| Thrombocytopeniaa | 40 (9.2) | 0 (0.0) | 1 (0.1) | <0.0001 | 1.0 | <0.0001 | 0.43 | 0.99 | 0.70 |
| Hyperbilirubinemiaa | 44 (10.1) | 1 (0.5) | 1 (0.1) | <0.0001 | 0.39 | <0.0001 | 0.82 | 0.94 | 0.68 |
| Hyperlactatemiaa | 168 (38.5) | 70 (35.9) | 320 (45.8) | 0.53 | 0.01 | 0.02 | 0.99 | 0.99 | 0.98 |
| Coagulopathya | 67 (15.4) | 2 (1.0) | 1 (0.1) | <0.0001 | 0.12 | <0.0001 | 0.87 | 0.86 | 0.67 |
| Classification, no. (%) | |||||||||
| Sepsis | 108 (24.8) | 99 (50.8) | 584 (83.6) | <0.0001 | <0.0001 | <0.0001 | 0.93 | 0.78 | 0.68 |
| Septic shock | 328 (75.2) | 96 (49.2) | 115 (16.5) | ||||||
aHyperthermia: temperature >38 °C, hypothermia: temperature <36 °C, tachycardia: heart rate >90/min, tachypnea: respiratory rate >20/min, hypotension: systolic blood pressure <90, mean arterial pressure <65 or systolic blood pressure decrease >40 mmHg from baseline, hypoxia: oxygen requirement to maintain oxygen saturation >90%, leukocytosis: WBC count >12 × 109/L, leucopenia: white blood cell count <4 × 109/L, increased creatinine: creatinine increase >176.8 mmol/L, thrombocytopenia: platelet count <100 × 109/L, hyperbilirubinemia: bilirubin >34.2 mmol/L, hyperlactatemia: lactate >2 mmol/L, coagulopathy: international normalized ratio (INR) >1
Sepsis-related interventions during the treatment period for patients with sepsis or septic shock in the three study phases: pre-intervention (A), intervention phase I (B) and intervention phase II (C)
| Variable | Pre-intervention | Intervention phase I | Intervention phase II |
|
| ||||
|---|---|---|---|---|---|---|---|---|---|
| All patients |
|
|
| B vs. A | C vs. B | C vs. A | B vs. A | C vs. B | C vs. A |
| Lactate measured at any time, no. (%) | 406 (93.1) | 191 (97.9) | 682 (97.6) | 0.01 | 1.0 | 0.0003 | 0.02 | 0.72 | 0.009 |
| Time to lactate (h), mean ± SD | 9.3 ± 22.1 | 2.5 ± 5.3 | 1.1 ± 3.7 | <0.0001 | 0.0008 | <0.0001 | 0.002 | 0.0002 | <0.0001 |
| Lactate (mmol/L), mean ± SD | 3.9 ± 3.6 | 3.3 ± 2.3 | 3.4 ± 5.5 | 0.01 | 0.93 | 0.03 | 0.76 | 0.28 | 0.26 |
| Measure lactate within 6 h, no. (%) | 270 (61.9) | 168 (86.2) | 663 (94.9) | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
| Blood culture obtained at any time, no. (%)a | 238 (54.6) | 119/194 (61.3) | 592/679 (87.2) | 0.11 | <0.0001 | <0.0001 | 0.16 | <0.0001 | <0.0001 |
| Time to blood culture (h), mean ± SD | 2.4 ± 6.7 | 0.9 ± 1.4 | 0.9 ± 2.5 | 0.001 | 0.94 | 0.0008 | 0.02 | 0.84 | 0.0001 |
| Blood culture before antibiotics, no. (%) | 219 (50.2) | 116 (59.5) | 565 (80.8) | 0.02 | <0.0001 | <0.0001 | 0.10 | <0.0001 | <0.0001 |
| Antibiotics administered at any time, no. (%)a | 266/269 (98.9) | 136/137 (99.3) | 439/448 (98.0) | 1.0 | 0.47 | 0.55 | 0.97 | 0.45 | 0.87 |
| Time to antibiotic administration (h), mean ± SD | 4.8 ± 6.7 | 3.0 ± 3.6 | 1.9 ± 3.3 | 0.0004 | 0.002 | <0.0001 | 0.002 | 0.002 | 0.01 |
| Antibiotics within 3 h, no. (%) | 295 (67.7) | 149 (76.4) | 625 (89.4) | <0.0001 | <0.0001 | <0.0001 | 0.01 | 0.0001 | <0.0001 |
aPatients who had cultures or received antibiotics prior to meeting sepsis and septic shock criteria were not included
a20 mL/kg of crystalloid fluids CVP central venous pressure, MAP mean arterial pressure, ScvO central venous oxygen saturation. Denominators are equal to ‘N’ in all three phases unless otherwise specified
Fig. 1Control chart with upper and lower control limits of the overall compliance with the resuscitation bundle and the mortality in the three phases. The two arrows on the chart show the time of initiation of the intervention phases I and II
Outcomes among patients with sepsis or septic shock in the three study phases: pre-intervention (A), intervention phase I (B) and intervention phase II (C) with adjustment to propensity scores
| Variable | Pre-intervention | Intervention phase I | Intervention phase II | Propensity scores adjusted OR or correlation coefficient* (95% CI, | ||
|---|---|---|---|---|---|---|
| All patients |
|
|
| B vs. A | C vs. B | C vs. A |
| Hospital mortality, no. (%) | 208 (47.7) | 60 (30.8) | 118 (16.9) | 0.73 (0.48–1.09, 0.13) | 0.78 (0.51–1.17, 0.23) | 0.71 (0.58–0.85, 0.003) |
| ICU LOS (days), mean ± SD | 13.3 ± 17.4 | 8.6 ± 8.3 | 5.1 ± 11.4 | −4.49 (−7.39 to −1.59, 0.002)* | −1.54 (−3.38 to 0.29, 0.09)* | −2.72 (−3.92 to −1.52, <0.0001)* |
| Mechanical ventilation, no. (%) | 265 (60.8) | 54 (27.7) | 78 (11.2) | 0.33 (0.22–0.49, <0.0001) | 0.64 (0.41–0.99, 0.05) | 0.45 (0.37–0.55, <0.0001) |
| ICU LOS among survivors (days), mean ± SD | 15.9 ± 19.5 | 11.9 ± 10.4 | 8.2 ± 13.8 | −5.88 (−11.44 to −0.22, 0.04)* | −1.05 (−5.22 to 3.10, 0.61)* | −3.55 (−6.13 to −0.98, 0.007)* |
| Hospital LOS (days), mean ± SD | 29.3 ± 33.9 | 25.7 ± 40.9 | 15.3 ± 23.5 | −1.37 (−8.28 to 5.53, 0.70)* | −8.42 (−13.29 to −3.54, 0.0007)* | −5.35 (−7.76 to −2.94, <0.0001)* |
| Hospital LOS among survivors (days), mean ± SD | 28.1 ± 30.8 | 24.7 ± 37.7 | 20.6 ± 28.6 | −1.76 (−12.09 to 8.57, 0.73)* | −6.22 (−16.9 to 4.48, 0.25)* | −3.45 (−7.83 to 0.92, 0.12)* |
LOS length of stay, * correlation coefficient (95% CI, p value)